Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia
Powles RL, Morgenstern GR, Kay HE et al. Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet 1983; 1: 612-615.
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma
Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. New Engl J Med 1989; 320: 197-204.
Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program
Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
Graft failure after bone marrow transplantation from unrelated donors using busulphan and cyclophosphamide for conditioning
Mehta J, Powles RL, Mitchell P et al. Graft failure after bone marrow transplantation from unrelated donors using busulphan and cyclophosphamide for conditioning. Bone Marrow Transplant 1994; 13: 583-587.
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation
Nemunaitis J, Singer JW, Buckner CD et al. Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood 1990; 76: 245-253.
Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation
Davies SM, Weisdorf DJ, Haake RJ et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 73-77.
Second marrow infusion for poor graft function after allogeneic marrow transplantation
Bolger GB, Sullivan KM, Storb R et al. Second marrow infusion for poor graft function after allogeneic marrow transplantation. Bone Marrow Transplant 1986; 1: 21-30.
Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia
in press
Mehta J, Mijovic A, Powles R et al. Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia. Bone Marrow Transplant 1996 (in press).
Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center
Powles R, Mehta J, Singhal S et al. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center. Bone Marrow Transplant 1995; 16: 241-247.
Adoptive immunotherapy with mismatched allogeneic peripheral blood lymphocytes (PBL) following autologous bone marrow transplantation (ABMT)
Nagler A, Ackerstein A, Or R et al. Adoptive immunotherapy with mismatched allogeneic peripheral blood lymphocytes (PBL) following autologous bone marrow transplantation (ABMT). Exp Hematol 1992; 20: 705.